Cancer blood test trialed to prevent unnecessary chemotherapy
(Walter and Eliza Hall Institute) Cancer patients could be spared unnecessary chemotherapy -- and its side-effects -- by a new blood test that is in clinical trials at more than 40 hospitals in Australia and New Zealand. The trial is one of the largest trials internationally to investigate a predictive blood test to guide cancer treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 17, 2018 Category: Cancer & Oncology Source Type: news

FDA Approves Talazoparib in BRCA+ Breast Cancer FDA Approves Talazoparib in BRCA+ Breast Cancer
Compared with standard chemotherapy, the PARP inhibitor extended progression-free survival for patients with advanced BCRA-positive breast cancer.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

AHA: After 2 Breast Cancer Diagnoses, Survivor Learns She Needs a New Heart
TUESDAY, Oct. 16, 2018 (American Heart Association) -- The hair loss, fatigue and nausea were a given. As a nurse, Toni C. Wild had seen patients faced with these common side effects of chemotherapy. What Wild did not expect when she was diagnosed... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 16, 2018 Category: General Medicine Source Type: news

Voices: Hiding My Cancer Under the Hijab
After breast cancer treatment, I hid my bald head in front of my family to avoid painful conversations about my illness. (Source: NYT Health)
Source: NYT Health - October 16, 2018 Category: Consumer Health News Authors: SAEMA KHANDAKAR, M.D. Tags: Muslim Veiling Breast Cancer Hair Baldness Chemotherapy Families and Family Life Source Type: news

Biased antagonism of CXCR4 avoids antagonist tolerance
Repeated dosing of drugs targeting G protein–coupled receptors can stimulate antagonist tolerance, which reduces their efficacy; thus, strategies to avoid tolerance are needed. The efficacy of AMD3100, a competitive antagonist of the chemokine receptor CXCR4 that mobilizes leukemic blasts from the bone marrow into the blood to sensitize them to chemotherapy, is reduced after prolonged treatment. Tolerance to AMD3100 increases the abundance of CXCR4 on the surface of leukemic blasts, which promotes their rehoming to the bone marrow. AMD3100 inhibits both G protein signaling by CXCR4 and β-arrestin1/2–depend...
Source: Signal Transduction Knowledge Environment - October 16, 2018 Category: Science Authors: Hitchinson, B., Eby, J. M., Gao, X., Guite-Vinet, F., Ziarek, J. J., Abdelkarim, H., Lee, Y., Okamoto, Y., Shikano, S., Majetschak, M., Heveker, N., Volkman, B. F., Tarasova, N. I., Gaponenko, V. Tags: STKE Research Articles Source Type: news

Childhood trauma, depression linked to higher risk of longer-term fatigue in breast cancer survivors
This study highlights the variability in people ’s experience of fatigue after treatment, which ultimately will allow for more personalized treatments for cancer survivors. In addition to psychosocial predictors, cancer treatments were also associated with fatigue trajectories. “Now that we know some of the risk factors for fatigue, and understand who are most at risk, we can really try to target those women and take more preventative measures to help them earlier in the course of their cancer experience,” said Ganz, who is also a distinguished professor of medicine at the David Geffen School of Medi...
Source: UCLA Newsroom: Health Sciences - October 15, 2018 Category: Universities & Medical Training Source Type: news

Milk thistle is not only good for your liver – it can protect you from the toxic effects of chemotherapy, too
(Natural News) You’ve probably heard of milk thistle, even if you’re not quite sure exactly what it is or what it can do for your health. In fact, there’s a chance you see it growing wild all the time and don’t even realize the power this humble weed possesses. Milk thistle has many great qualities,... (Source: NaturalNews.com)
Source: NaturalNews.com - October 15, 2018 Category: Consumer Health News Source Type: news

Cancer survivors at risk for heart failure during, after pregnancy
(American College of Cardiology) Young women previously treated for cancer with chemotherapy or radiation therapy with a prior history of cardiotoxicity are more likely to develop clinical congestive heart failure (CHF) during and after pregnancy, according to a study published today in the Journal of the American College of Cardiology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2018 Category: Cancer & Oncology Source Type: news

Being deficient in magnesium increases your risk of pancreatic cancer by 76%
(Natural News) Pancreatic cancer: It’s a silent killer that now claims the lives of as many as 55,000 people every single year. But a new study suggests that magnesium, a simple, inexpensive trace mineral, may be powerfully effective in helping to stamp it out without the need for chemotherapy or radiation. The latest World Health... (Source: NaturalNews.com)
Source: NaturalNews.com - October 13, 2018 Category: Consumer Health News Source Type: news

Ajwa dates preserve liver function in cancer patients
(Natural News) Most people have recently found an increased interest in alternative medicines for cancer treatment, thanks to rising mortality rates and adverse side effects following chemotherapy and radiotherapy. An alternative believed to possess anti-cancer properties are ajwa dates (Phoenix dactylifera L.). In a study published in the journal BMC Complementary and Alternative Medicine, ajwa date extracts were... (Source: NaturalNews.com)
Source: NaturalNews.com - October 13, 2018 Category: Consumer Health News Source Type: news

UK Study Matches Mesothelioma Treatments to Genetic Profile
University of Leicester researchers soon will open the first molecularly stratified clinical trial for malignant mesothelioma with the hope of moving the future of treatment toward more personalization. The phase II trial in the United Kingdom is designed to match therapy with a patient’s specific genetic profile. “We’re trying to bring the right drug to the right patient at the right time,” Professor Dean Fennell, chair of thoracic medical oncology at Leicester and chief trial investigator, told Asbestos.com. “We need to find different treatments that work for different people. This is a step...
Source: Asbestos and Mesothelioma News - October 12, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Bristol-Myers' Opdivo fails to meet lung cancer study goal
Bristol-Myers Squibb Co said on Friday that its blockbuster cancer drug Opdivo failed to meet the main goal in a late-stage trial on patients with a type of lung cancer, whose condition had relapsed after chemotherapy. (Source: Reuters: Health)
Source: Reuters: Health - October 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Turmeric OUTPERFORMS conventional chemotherapy drugs in treating all forms of cancer
(Natural News) The golden hue of turmeric is unforgettable; for thousands of years, the spice has been used in both the kitchen and the medicine cabinet. But until recently, turmeric hasn’t been given its due. While the mainstream media and puppets of conventional medicine decry virtually any and all forms of natural medicine, the benefits... (Source: NaturalNews.com)
Source: NaturalNews.com - October 11, 2018 Category: Consumer Health News Source Type: news

Probiotics help body survive harmful effects of chemo better than antibiotics
(Natural News) Chemotherapy has been used as both first-line and second-line therapy in cancer treatments, especially in conventional medicine. However, the treatment is also known for its adverse effects to the body, which can range from extreme fatigue to an increased risk of infection. In recent studies, scientists have shown that adding probiotics to the... (Source: NaturalNews.com)
Source: NaturalNews.com - October 11, 2018 Category: Consumer Health News Source Type: news

Immune cells in triple-negative breast cancer offer potential therapeutic target
(University of Pennsylvania) New research led by the University of Pennsylvania School of Veterinary Medicine's Rumela Chakrabarti reveals how immune cells called myeloid-derived immunosuppressor cells contribute to the progression of triple-negative breast cancer, a particularly aggressive form of the disease. Pairing chemotherapy with a drug that blocks these cells may one day help stem the cancer's spread. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 11, 2018 Category: International Medicine & Public Health Source Type: news

Nurse issues personal warning on aggressive breast cancer
A nurse is urging women to be watchful for signs of inflammatory breast cancer (IBC), after beginning an 18-month course of chemotherapy treatment for the condition herself. (Source: Nursing Times)
Source: Nursing Times - October 9, 2018 Category: Nursing Source Type: news

Chemotherapy has harmed Ruth Bader Ginsburg’s brain… she had to be reminded by the audience what the 14th Amendment says
(Natural News) As the insane Left continues to vent its rage over Supreme Court nominee Brett Kavanaugh, claiming he’s somehow “unfit” for the high court because a few women have accused him – without proof and corroboration – of sexual assault, at least he’s got one thing a current SCOTUS justice doesn’t have. His mind.... (Source: NaturalNews.com)
Source: NaturalNews.com - October 7, 2018 Category: Consumer Health News Source Type: news

Want to live for ever? Flush out your zombie cells
As time passes, the number of damaged, ‘senescent’ cells in our bodies increases. These in turn are responsible for many effects of ageing. Now scientists are working to eliminate themIn a lab just south of San Francisco I am looking at two blown-up images of microscope slides on a computer screen, side by side. The slides are the same cross-sections of mouse knees from a six-month-old and an 18-month-old animal. The older mouse ’s image has a splattering of little yellow dots, the younger barely any. That staining indicates the presence of so-called senescent cells – “zombie cells” that...
Source: Guardian Unlimited Science - October 6, 2018 Category: Science Authors: Zo ë Corbyn Tags: Ageing Medical research Biology Science Source Type: news

Hospitalization Rates Vary by Type of Chemo for Elderly Breast Cancer Patients
Different cytotoxic chemotherapy regimens are associated with varying rates of hospitalization following their use in older women with stage IV breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - October 5, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Medical News Today: What are the side effects of radiation for breast cancer?
Radiation can be an effective treatment for breast cancer, but it does have side effects. Doctors may recommend this therapy in combination with others, such as surgery and chemotherapy. Learn more about how radiation for breast cancer affects the body and what short- and long-term side effects to expect. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 5, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Pembrolizumab Alone or With Chemotherapy for PD-L1 –Positive NSCLC?
Pembrolizumab plus chemotherapy failed to improve survival compared with pembrolizumab alone in patients with non –small-cell lung cancer. (Source: CancerNetwork)
Source: CancerNetwork - October 4, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

' Unexpected': Age 35 Key to Ovarian Function After Chemo for HL'Unexpected': Age 35 Key to Ovarian Function After Chemo for HL
Age impacts recovery of ovarian function after chemotherapy for Hodgkin's lymphoma, even when regimens considered less toxic are used.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Review Highlights Better Targets for Mesothelioma Therapy
A review on targeted therapies for malignant pleural mesothelioma (MPM) provides fresh insight into why this cancer is so difficult to treat and ideas for improving outcomes. “Despite more than two decades of intensive research on the possible treatments for MPM, the results have so far been disappointing,” the authors wrote. According to the in-depth review, published in Critical Reviews in Hematology/Oncology, the next steps toward more tailored mesothelioma treatment will come from learning more about the changes driving abnormal cell communication. Researchers will use this information to personalize treatm...
Source: Asbestos and Mesothelioma News - October 4, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

How Scientists Are Treating Breast Cancer Using the Immune System
As a pharmacist, Kathy James considers herself well educated about the importance of getting regular cancer screenings. Even though the 55-year-old had no history of cancer in her family, she never skipped her regular mammograms, and she gave herself regular breast exams. So she was dumbfounded when, during one of those self-exams in May 2017, she felt a marble-size lump in her left breast. A visit to the doctor confirmed it. “The radiologist came in with his hands in his pockets and looked down and said, ‘It doesn’t look good,'” James says. After a biopsy, James and her husband learned she had meta...
Source: TIME: Health - October 4, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized breast cancer news Frontiers of Medicine Source Type: news

How Scientists Are Treating Breast Cancer Using the Immune System
As a pharmacist, Kathy James considers herself well educated about the importance of getting regular cancer screenings. Even though the 55-year-old had no history of cancer in her family, she never skipped her regular mammograms, and she gave herself regular breast exams. So she was dumbfounded when, during one of those self-exams in May 2017, she felt a marble-size lump in her left breast. A visit to the doctor confirmed it. “The radiologist came in with his hands in his pockets and looked down and said, ‘It doesn’t look good,'” James says. After a biopsy, James and her husband learned she had meta...
Source: TIME: Science - October 4, 2018 Category: Science Authors: Alice Park Tags: Uncategorized breast cancer news Frontiers of Medicine Source Type: news

Mouse study mirrors human findings that link chemotherapy and APOE4 to cognitive issues
(Georgetown University Medical Center) A chemotherapy drug commonly used to treat breast cancer alters brain structure and function in mice that express the human APOE4 gene, known to significantly increase risk of developing Alzheimer's disease, according to a study led by Georgetown investigators. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

Duvelisib has marked response, survival benefit in difficult-to-treat leukemia and lymphoma
(American Society of Hematology) For some patients with difficult-to-treat leukemia and lymphoma, the investigational oral medicine duvelisib may significantly improve disease outcomes, according to phase III trial data published today in the journal Blood. The DUO trial studied duvelisib versus ofatumumab, an approved standard-of-care chemotherapy for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). According to the study, duvelisib extended PFS from a median of 9.9 months on ofatumumab to 13.3 months. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

Chemotherapy may lead to mitochondrial dysfunction in skeletal muscle
(American Physiological Society) Chemotherapy drugs to treat breast cancer may promote muscle mitochondrial dysfunction, according to new research. Dysfunctional mitochondria, the energy centers of the cells, may contribute to fatigue and weakness that some people with breast cancer experience through the course of disease treatment. The study is published ahead of print in the American Journal of Physiology--Cell Physiology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

Treatment Linked to Cognitive Scores in Breast Cancer Survivors
For older survivors, those receiving chemotherapy have increasing worse APE scores (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - October 4, 2018 Category: Psychiatry Tags: Gynecology, Neurology, Oncology, Psychiatry, Journal, Source Type: news

Link Found for Alzheimer's Gene, 'Chemo Brain'
Breast cancer survivors who have a gene linked to Alzheimer’s disease and who underwent chemotherapy were more likely to have long-term impairment in brain function, researchers say. (Source: WebMD Health)
Source: WebMD Health - October 3, 2018 Category: Consumer Health News Source Type: news

Most older breast cancer patients do not suffer mental decline after chemo
(Reuters Health) - Most older women who get chemotherapy for breast cancer do not experience problems with cognition in the first two years after diagnosis and treatment, a new study finds. (Source: Reuters: Health)
Source: Reuters: Health - October 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Prioritizing Patients in Push Toward Value-Based Care
Previously, we discussed how medtech companies can prepare for the transition to value-based care. Specifically, these organizations need to start going beyond just providing medical devices and products to their customers and focus more on providing comprehensive and connected systems that help deliver integrated care. This, however, needs common collaboration between vendors, which are too often direct competitors and therefor pushing for their own more expensive complete solutions.   Interoperability and health data exchange have become a top priority for providers. Along with EMRs, all machines being utiliz...
Source: MDDI - October 3, 2018 Category: Medical Devices Authors: Corrina Kane Tags: Business Source Type: news

' Transformational' Results in Squamous Cell Lung Cancer'Transformational' Results in Squamous Cell Lung Cancer
An immuno-chemotherapy combination again moves the bar forward in a difficult-to-treat subset of squamous cell lung cancer patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

New Cancer Treatments Just Won 2 Scientists a Nobel Prize. Here ’s How They Work
It wasn’t the Nobel Committee that reached James Allison first on Monday to inform him that he had won the coveted annual prize in Physiology or Medicine. It was his son who broke the news with a 5:30 am phone call. Minutes later, a Swedish reporter reached him before the committee could. “I was like, ‘Oh my God, it happened,’” Allison says to TIME. “I’m just in shock, I guess.” Allison, chair of immunology at the University of Texas MD Anderson Cancer Center, was awarded the Nobel for his discovery in 1994 in mice that led to an entirely new class of anti-cancer drugs called...
Source: TIME: Health - October 1, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

New Cancer Treatments Just Won Two Scientists a Nobel Prize. Here ’s How They Work
It wasn’t the Nobel Committee that reached James Allison first on Monday to inform him that he had won the coveted annual prize in Physiology or Medicine. It was his son who broke the news with a 5:30 am phone call. Minutes later, a Swedish reporter reached him before the committee could. “I was like, ‘Oh my God, it happened,’” Allison says to TIME. “I’m just in shock, I guess.” Allison, chair of immunology at the University of Texas MD Anderson Cancer Center, was awarded the Nobel for his discovery in 1994 in mice that led to an entirely new class of anti-cancer drugs called...
Source: TIME: Health - October 1, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Chef Ryan Riley holds cookery classes for cancer patients
Chef Ryan Riley is helping chemotherapy patients taste food again. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 30, 2018 Category: Consumer Health News Source Type: news

After Decades, New Standard of Care in Small Cell Lung Cancer After Decades, New Standard of Care in Small Cell Lung Cancer
The first treatment advance in decades in small cell lung cancer couples immunotherapy with standard chemotherapy to move the bar.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Breakthrough Treatment Helps Prolong Life for People with Metastatic Lung Cancer
September 26, 2018—(BRONX, NY)—When lung cancer has spread, or metastasized, to other parts of the body, standard chemotherapy offers only a modest survival benefit. Now, in a major advance described in today’s issue of theNew England Journal of Medicine, an international team, including researchers from Albert Einstein College of Medicine and Montefiore Health System, report that combining chemotherapy with the immunotherapy drug Keytruda extends the lives of people with metastatic squamous non-small cell lung cancer (NSCLC) by more than 40 percent compared with chemotherapy alone—a significant imp...
Source: Einstein News - September 26, 2018 Category: Universities & Medical Training Source Type: news

International Symposium on Mesothelioma to Focus on Immunotherapy
The eighth annual International Symposium on Malignant Pleural Mesothelioma Saturday at UCLA will reflect the rapidly evolving philosophy on future treatment of this rare cancer. Change is coming. The Symposium, which was first held in 2011 to help bring awareness to lung-sparing surgery, will highlight groundbreaking discoveries and the latest advances in immunotherapy and gene therapy — believed to be the future of cancer care. The longtime chemotherapy and surgery standard-of-care routine is fading. The symposium at the Luskin Conference Center on the UCLA campus in Los Angeles will help explain why. “There ...
Source: Asbestos and Mesothelioma News - September 26, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Durvalumab New Standard in Stage III Unresectable Lung Cancer Durvalumab New Standard in Stage III Unresectable Lung Cancer
Now with data showing an overall survival advantage, the immunotherpy sets new standard of care in stage III unresectable lung cancer following concurrent chemotherapy and radiotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 26, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Study: Aggressive Surgery Underutilized with Pleural Mesothelioma
Aggressive surgery for the treatment of malignant pleural mesothelioma is being underutilized, costing patients significant survival time, according to a recent study. Researchers found mesothelioma patients from all three histological subtypes — epithelioid, biphasic and sarcomatoid — can benefit from surgery, despite a reluctance to perform it today. The National Comprehensive Cancer Network (NCCN), a nationwide alliance of leading cancer centers, encourages surgery only for epithelioid patients. This eliminates the option for almost 40 percent of those diagnosed with mesothelioma. “Surgery is underutil...
Source: Asbestos and Mesothelioma News - September 25, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Roche ’s Tecentriq in combination with chemotherapy helped people live significantly longer as an initial treatment for people with extensive-stage small cell lung cancer
Roche today announced positive results from the Phase III IMpower133 study of Tecentriq ® (atezolizumab) plus carboplatin and etoposide (chemotherapy) for the initial (first-line) treatment of people with previously-untreated extensive-stage small cell lung cancer (ES-SCLC). (Source: Roche Media News)
Source: Roche Media News - September 25, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s Tecentriq in combination with chemotherapy helped people live significantly longer as an initial treatment for people with extensive-stage small cell lung cancer
Roche today announced positive results from the Phase III IMpower133 study of Tecentriq ® (atezolizumab) plus carboplatin and etoposide (chemotherapy) for the initial (first-line) treatment of people with previously-untreated extensive-stage small cell lung cancer (ES-SCLC). (Source: Roche Investor Update)
Source: Roche Investor Update - September 25, 2018 Category: Pharmaceuticals Source Type: news

Advances in Treatment and Care in Metastatic Breast Cancer Advances in Treatment and Care in Metastatic Breast Cancer
Effective first-line chemotherapy and targeted therapy in patients with metastatic breast cancer may offer the possibility of cure.Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 25, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Roche ’s Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer
Roche today announced results from the Phase III IMpower132 study of Tecentriq ® (atezolizumab) plus pemetrexed and platinum-based chemotherapy (cisplatin or carboplatin) for the initial (first-line) treatment of people with non-squamous, non-small cell lung cancer (NSCLC). (Source: Roche Media News)
Source: Roche Media News - September 24, 2018 Category: Pharmaceuticals Source Type: news

Roche ’s Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer
Roche today announced results from the Phase III IMpower132 study of Tecentriq ® (atezolizumab) plus pemetrexed and platinum-based chemotherapy (cisplatin or carboplatin) for the initial (first-line) treatment of people with non-squamous, non-small cell lung cancer (NSCLC). (Source: Roche Investor Update)
Source: Roche Investor Update - September 24, 2018 Category: Pharmaceuticals Source Type: news

What Causes Hyperkalemia?
Discussion Potassium (K+) is an alkali metal (Group 1 of periodic table with Hydrogen, Lithium and Sodium) with an anatomic number of 19. Its chemical symbol K, comes from the medieval Latin, kalium which means potash (mainly potassium carbonate or potassium hydroxide), the substance it was first isolated from. Potassium is an important cation and it mainly resides in the intracellular fluid with only a small amount in the extracellular fluid. Potassium regulates cell volume, pH and enzyme functions. Hyperkalemia is defined as a potassium level> 5.5 mEq/L in children and> 6.0 mEq/L in newborns. Hyperkalemia incre...
Source: PediatricEducation.org - September 24, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Alternative therapies for breast cancer
(Natural News) When you think of breast cancer, surgery and chemotherapy probably come immediately to mind. Many patients often end up undergoing one or both of these treatments, and the prospect of going under the knife or being injected with chemicals can be scarier to some people than the diagnosis itself. However, some patients are... (Source: NaturalNews.com)
Source: NaturalNews.com - September 22, 2018 Category: Consumer Health News Source Type: news

Students surprise teacher on last day of chemo: 'I'm extremely grateful'
Aa mob of students surprised their teacher by ringing bells outside her at home on the day she finished chemotherapy. (Source: ABC News: Health)
Source: ABC News: Health - September 21, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Students surprise teacher on last day of chemo, 'I'm extremely grateful,' she says
Aa mob of students surprised their teacher by ringing bells outside her at home on the day she finished chemotherapy. (Source: ABC News: Health)
Source: ABC News: Health - September 21, 2018 Category: Consumer Health News Tags: GMA Source Type: news